Photos - Pharma Japan -

Wednesday, October.17.2018

Remember Me

Home＞Photo


I/O Pioneers Win Nobel Prize in Medicine; Honjo Prods Japan Firms to Make More Academic Investment at Home (Oct.02)		MHLW Proposes “Institutionalization” of Conditional Approval, Sakigake Schemes (Oct.01)		Konica Minolta Embarks on Precision Medicine Biz, Ex-GSK/AZ Exec Takes Helm (Oct.01)


New Treatment GL for Statin Intolerance Compiled by Atherosclerosis Society, 3 Other Academic Societies (Oct.01)		Alnylam Plants Flag in Japan Soil, Eyes 4 RNAi Therapeutic Launches in 5 Years (Sep.28)		MHLW Sees October 2019 “Natural” Timing for Tax Hike-Linked Price Revision, but Likely to Moot Other Options Too (Sep.27)


ASKA’s Generic Valsartan Might Cause Cancer in 1 in 15,000-30,000 Patients: MHLW (Sep.27)		I/O in Lung Cancer - 6: Analyst Says US Merck Claimed Victory in 2018 ASCO Confab, Applauds Trial Designs for Keytruda (Sep.26)		October 2019 “Only Option” for Drug Price Revision Tied to Sales Tax Hike: New FPMAJ Chief (Sep.25)


MHLW Panel Members Share Views on One Key Topic toward PMD Law Amendment; Next Meeting Scheduled Soon: Official (Sep.25)		Opdivo Holds Promise as New Option for Malignant Pleural Mesothelioma: Pulmonary Specialist (Sep.21)		Growing Number of Drug Makers Introducing LGBT-Friendly Policies (Sep.20)

＜ Prev 1 2 3 4 5 6 7 8 9 10 Next ＞

There’s Room for Growth in Biosimilar Space, but Who Will Grab It?

G1/G2 Rule：
G1/G2ルール

Finding Captains in Your Organization

ADR Victim Relief Claims Fall below 1,500 in FY2017: MHLW(Oct.17)

Japan Wholesaler Chief Suzuki Becomes IFPW Chairman(Oct.16)

As Abe Vows to Deliver on Tax Hike Plan, 3 Pharma Groups to Push for October 2019 Price Revision(Oct.16)

Research Group Builds New Pathogenic Variants Database for Japanese Hereditary Breast Cancer(Oct.16)

Chugai’s Satralizumab Cuts Relapse Risk of Neuromyelitis Optica Spectrum Disorder(Oct.16)

1.: MHLW Panelists Frown on Use of Economic ...
2.: Hep C Market Shrinking towards Disease E...
3.: MOF Reiterates Drug Cost Optimization, b...
4.: Nobel Laurate Honjo Prods Minister on In...
4.: Chugai Sues Daiichi Sankyo, Pfizer over ...